Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 3Phase 2 1

Status

Completed 7

Sponsor Class

OTHER 3NIH 2NETWORK 1INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 7Genitourinary 2Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 7Osteoporosis 1Cardiovascular Diseases 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Completed × Raloxifene Hydrochloride × Breast × Clear all
NCT00723398 2018-11-01

Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

Milton S. Hershey Medical Center

Phase NA Completed
266 enrolled 20 charts
Breast

Breast Neoplasms

NCT00687102 2018-09-12

Co-STAR

Wake Forest University Health Sciences

Phase 3 Completed
1,498 enrolled 13 charts
Breast

Breast Neoplasms

NCT00003906 2015-10-06

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

NSABP Foundation Inc

Phase 3 Completed
19,747 enrolled
Breast

Breast Neoplasms

NCT00031850 2013-06-26

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

National Cancer Institute (NCI)

Phase NA Completed
150 enrolled
Breast

Breast Neoplasms

NCT00019500 2013-06-20

Raloxifene in Preventing Breast Cancer in Premenopausal Women

National Cancer Institute (NCI)

Phase 2 Completed
Breast

Breast Neoplasms

NCT00031811 2012-05-28

Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer

OHSU Knight Cancer Institute

Phase NA Completed
80 enrolled
Breast

Breast Neoplasms, Osteoporosis

NCT00190593 2007-01-26

Raloxifene Use for The Heart

Eli Lilly and Company

Phase 3 Completed
10,000 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡